Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.6B | 8.2B | 8.4B | 8.5B |
| Cost of revenue | 6.4B | 6.0B | 6.4B | 6.3B |
| Gross profit | 2.3B | 2.2B | 2.0B | 2.2B |
| Operating expense | ||||
| Research & development | 357M | 344M | 356M | 359M |
| Selling general and admin | 779M | 754M | 801M | 807M |
| Other operating expenses | 4M | 5M | 181M | 10M |
| Operating income | 1.1B | 1.0B | 664M | 963M |
| Non operating interest income | ||||
| Income | 52M | 60M | 34M | 47M |
| Expense | 87M | 77M | 89M | 83M |
| Other income expense | 152M | 114M | 53M | 116M |
| Pretax income | 1.2B | 1.1B | 662M | 1.0B |
| Tax provision | 297M | 267M | 217M | 200M |
| Net income | 928M | 850M | 445M | 843M |
| Basic EPS | 6.5 | 6.0 | 3.0 | 5.9 |
| Diluted EPS | 6.4 | 6.0 | 3.0 | 5.9 |
| Basic average shares | 137.8M | 137.6M | 137.4M | 137.2M |
| Diluted average shares | 138.5M | 138.3M | 138.4M | 138.1M |
| EBITDA | 1.6B | 1.5B | 1.1B | 1.4B |
| Net income from continuing op. | 928M | 850M | 445M | 843M |
| Minority interests | -38M | -26M | -27M | -34M |
| Preferred stock dividends | — | — | — | — |